FDA.reportPublic FDA data

Application 211324

Type
ANDA
Sponsor
CADILA PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RALOXIFENE HYDROCHLORIDERALOXIFENE HYDROCHLORIDETABLET;ORAL60MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-6177Raloxifene hydrochlorideRaloxifene hydrochlorideA-S Medication SolutionsANDACurrent
50090-6177Raloxifene hydrochlorideRaloxifene hydrochlorideA-S Medication SolutionsANDACurrent
71209-082Raloxifene hydrochlorideRaloxifene hydrochlorideCadila Pharmaceuticals LimitedANDACurrent
71209-082Raloxifene hydrochlorideRaloxifene hydrochlorideCadila Pharmaceuticals LimitedANDACurrent
72241-010Raloxifene hydrochlorideRaloxifene hydrochlorideModavar Pharmaceuticals LLCANDACurrent